| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
REVIEW |
a Division of Molecular Oncology, IRCC, Institute for Cancer Research, University of Torino School of Medicine, 10060 Candiolo, Torino, Italy
The scatter factors, which include hepatocyte growth factor and macrophage stimulating protein, stand out from other cytokines because of their uncommon biological properties. In addition to promoting cell growth and protection from apoptosis, they are involved in the control of cell dissociation, migration into extracellular matrices, and a unique process of differentiation called `branching morphogenesis'. Through the concerted regulation of these complex phenomena, scatter factors promote development, regeneration, and reconstruction of normal organ architecture. In transformed epithelia, scatter factors can mediate tumor invasive growth, a harmful feature of neoplastic progression in which cancer cells invade surrounding tissues, penetrate across the vascular walls, and eventually disseminate throughout the body, giving rise to systemic metastases. A much-debated issue in basic biology, which has strong implications for experimental medicine, is how to dissociate the favorable effects of growth factors from their adverse ones. Accordingly, to find agonists or antagonists with potential therapeutic applications is a crucial undertaking for current research. Domain-mapping analyses of growth factor molecules can help to isolate specific structural requirements for the induction of selective biological effects. Based on the observation that certain growth factors must undergo posttranslational modifications to exert a full response, it is possible to interfere with their activation mechanisms to modulate their functions. Finally, the identification of cell type-specific coreceptors able to potentiate their activity allows drawing of a functional body map, where some organs or tissues may be more responsive than others to growth factors. This review is focused on how, and to what extent, scatter factors can behave `well' or `badly' according to their molecular structure, the way they are activated, and the way they interact with cell surface receptors and coreceptors.—Trusolino, L., Pugliese, L., Comoglio, P. M. Interactions between scatter factors and their receptors: hints for therapeutic applications. FASEB J. 12, 1267–1280 (1998)
Key Words: hepatocyte growth factor/scatter factor • macrophage stimulating protein • c-MET • RON • tyrosine kinases • growth factors
This article has been cited by other articles:
|
|
 |
|
  G Ricci, A Catizone, and M Galdieri Expression and functional role of hepatocyte growth factor and its receptor (c-met) during fetal mouse testis development J. Endocrinol., December 1, 2006; 191(3): 559 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ohnishi, K. Kakimoto, K. Bandow, C. J. Lowenstein, Y. Daikuhara, and T. Matsuguchi Mature Hepatocyte Growth Factor/Scatter Factor on the Surface of Human Granulocytes Is Released by a Mechanism Involving Activated Factor Xa. J. Immunol., June 1, 2006; 176(11): 6945 - 6953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Uehara, K. Muramoto, T. Imamura, K. Nakayama, J. Potempa, J. Travis, S. Sugawara, and H. Takada Arginine-Specific Gingipains from Porphyromonas gingivalis Stimulate Production of Hepatocyte Growth Factor (Scatter Factor) through Protease-Activated Receptors in Human Gingival Fibroblasts in Culture J. Immunol., November 1, 2005; 175(9): 6076 - 6084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Matsuzaki, M. Canis, J.L. Pouly, P. Dechelotte, K. Okamura, and G. Mage The macrophage stimulating protein/RON system: a potential novel target for prevention and treatment of endometriosis Mol. Hum. Reprod., May 1, 2005; 11(5): 345 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Basar, Y. Shen, and K. Ireton Redundant Roles for Met Docking Site Tyrosines and the Gab1 Pleckstrin Homology Domain in InlB-Mediated Entry of Listeria monocytogenes Infect. Immun., April 1, 2005; 73(4): 2061 - 2074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Tacchini, C. De Ponti, E. Matteucci, R. Follis, and M.A. Desiderio Hepatocyte growth factor-activated NF-{kappa}B regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines Carcinogenesis, November 1, 2004; 25(11): 2089 - 2100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Kirchhofer, M. Peek, W. Li, J. Stamos, C. Eigenbrot, S. Kadkhodayan, J. M. Elliott, R. T. Corpuz, R. A. Lazarus, and P. Moran Tissue Expression, Protease Specificity, and Kunitz Domain Functions of Hepatocyte Growth Factor Activator Inhibitor-1B (HAI-1B), a New Splice Variant of HAI-1 J. Biol. Chem., September 19, 2003; 278(38): 36341 - 36349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ding, T. Merkulova-Rainon, Z. C. Han, and G. Tobelem HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro Blood, June 15, 2003; 101(12): 4816 - 4822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wislez, N. Rabbe, J. Marchal, B. Milleron, B. Crestani, C. Mayaud, M. Antoine, P. Soler, and J. Cadranel Hepatocyte Growth Factor Production by Neutrophils Infiltrating Bronchioloalveolar Subtype Pulmonary Adenocarcinoma: Role in Tumor Progression and Death Cancer Res., March 15, 2003; 63(6): 1405 - 1412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Copp, M. Marino, M. Banerjee, P. Ghosh, and P. van der Geer Multiple Regions of Internalin B Contribute to Its Ability to Turn on the Ras-Mitogen-activated Protein Kinase Pathway J. Biol. Chem., February 28, 2003; 278(10): 7783 - 7789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. H. Van Aken, O. De Wever, L. Van Hoorde, E. Bruyneel, J.-J. De Laey, and M. M. Mareel Invasion of Retinal Pigment Epithelial Cells: N-cadherin, Hepatocyte Growth Factor, and Focal Adhesion Kinase Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 463 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. A. McBain, J. V. Forrester, and C. D. McCaig HGF, MAPK, and a Small Physiological Electric Field Interact during Corneal Epithelial Cell Migration Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 540 - 547. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Peek, P. Moran, N. Mendoza, D. Wickramasinghe, and D. Kirchhofer Unusual Proteolytic Activation of Pro-hepatocyte Growth Factor by Plasma Kallikrein and Coagulation Factor XIa J. Biol. Chem., November 27, 2002; 277(49): 47804 - 47809. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Grenier, S. Chollet-Martin, B. Crestani, C. Delarche, J. El Benna, A. Boutten, V. Andrieu, G. Durand, M.-A. Gougerot-Pocidalo, M. Aubier, et al. Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils Blood, April 15, 2002; 99(8): 2997 - 3004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Delehedde, M. Lyon, R. Vidyasagar, T. J. McDonnell, and D. G. Fernig Hepatocyte Growth Factor/Scatter Factor Binds to Small Heparin-derived Oligosaccharides and Stimulates the Proliferation of Human HaCaT Keratinocytes J. Biol. Chem., March 29, 2002; 277(14): 12456 - 12462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Bierne and P. Cossart InlB, a surface protein of Listeria monocytogenes that behaves as an invasin and a growth factor J. Cell Sci., January 9, 2002; 115(17): 3357 - 3367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tacchini, P. Dansi, E. Matteucci, and M. A. Desiderio Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells Carcinogenesis, September 1, 2001; 22(9): 1363 - 1371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Catizone, G. Ricci, and M. Galdieri Expression and Functional Role of Hepatocyte Growth Factor Receptor (C-MET) during Postnatal Rat Testis Development Endocrinology, May 1, 2001; 142(5): 1828 - 1834. [Abstract] [Full Text]
|
|
|
|
 |
|
 X. Xin, S. Yang, G. Ingle, C. Zlot, L. Rangell, J. Kowalski, R. Schwall, N. Ferrara, and M. E. Gerritsen Hepatocyte Growth Factor Enhances Vascular Endothelial Growth Factor-Induced Angiogenesis in Vitro and in Vivo Am. J. Pathol., March 1, 2001; 158(3): 1111 - 1120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. LINDNER, A. MENRAD, E. GHERARDI, G. MERLINO, P. WELKER, B. HANDJISKI, B. ROLOFF, and R. PAUS Involvement of hepatocyte growth factor/scatter factor and Met receptor signaling in hair follicle morphogenesis and cycling FASEB J, February 1, 2000; 14(2): 319 - 332. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. BOULTON A role for hepatocyte growth factor in diabetic retinopathy? Br. J. Ophthalmol., July 1, 1999; 83(7): 763 - 764. [Full Text]
|
|
|
|
|
|
J. Deakin and M Lyon Differential regulation of hepatocyte growth factor/scatter factor by cell surface proteoglycans and free glycosaminoglycan chains J. Cell Sci., January 6, 1999; 112(12): 1999 - 2009. [Abstract] [PDF]
|
|
|
|
|
|
T. Renne, J. Dedio, G. David, and W. Muller-Esterl High Molecular Weight Kininogen Utilizes Heparan Sulfate Proteoglycans for Accumulation on Endothelial Cells J. Biol. Chem., October 20, 2000; 275(43): 33688 - 33696. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lyon, J. A. Deakin, and J. T. Gallagher The Mode of Action of Heparan and Dermatan Sulfates in the Regulation of Hepatocyte Growth Factor/Scatter Factor J. Biol. Chem., January 4, 2002; 277(2): 1040 - 1046. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
